Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Werewolf Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q4 2022
- Shares held
- 24.0M
- +3.10M (+14.8%) vs. Q4 2022
- Total value
- $62.5M
- +$19.6M (+45.8%) vs. Q4 2022
- New holders
- 7
- 12 more added
- Sold out
- 8
- 8 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.2M |
| Q1 2024 | 61 | $209.0M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $83.5M |
| Q4 2021 | 51 | $228.3M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Glassman Wealth Services | 5 | $13 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 96 | $250 | 0.00% | +2+2.1% | Added |
| JPMorgan Chase & Co | 748 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,000 | $2.60K | 0.00% | −448−30.9% | Reduced |
| Financial Perspectives, Inc | 1,250 | $3.25K | 0.00% | +1,000+400.0% | Added |
| Tower Research Capital LLC (TRC) | 1,524 | $4.00K | 0.00% | −5,622−78.7% | Reduced |
| FMR LLC | 2,100 | $5.46K | 0.00% | +2,100 | New |
| Morgan Stanley | 2,500 | $6.50K | 0.00% | −12−0.5% | Reduced |
| Dimensional Fund Advisors LP | 13,326 | $34.6K | 0.00% | −2,880−17.8% | Reduced |
| Bailard, Inc. | 18,127 | $47.1K | 0.00% | +18,127 | New |
| Prudential Financial Inc | 19,800 | $51.5K | 0.00% | −1,200−5.7% | Reduced |
| Northern Trust Corp | 19,906 | $51.8K | 0.00% | +1,467+8.0% | Added |
| Two Sigma Investments, LP | 25,837 | $67.2K | 0.00% | −1,348−5.0% | Reduced |
| HBK Sorce Advisory LLC | 26,454 | $68.8K | 0.00% | +26,454 | New |
| Renaissance Technologies LLC | 34,100 | $89.0K | 0.00% | −44,123−56.4% | Reduced |
| BlackRock Inc. | 38,994 | $101.4K | 0.00% | +456+1.2% | Added |
| Man Group plc | – | $117.3K | 0.00% | – | New |
| Edgewood Management LLC | 50,000 | $130.0K | 0.00% | +50,000 | New |
| State Street Corp | 50,768 | $132.0K | 0.00% | +17,800+54.0% | Added |
| Schonfeld Strategic Advisors LLC | 73,418 | $190.9K | 0.00% | +73,418 | New |
| Acadian Asset Management LLC | 78,671 | $203.0K | 0.00% | +49,170+166.7% | Added |
| Bridgeway Capital Management, LLC | 81,711 | $212.4K | 0.01% | 00.0% | Unchanged |
| Marshall Wace, LLP | 120,936 | $314.4K | 0.00% | +120,936 | New |
| Geode Capital Management, LLC | 129,832 | $337.6K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 397,808 | $1.03M | 0.01% | +191,607+92.9% | Added |
| Vanguard Group Inc | 463,914 | $1.21M | 0.00% | +14,987+3.3% | Added |
| Laurion Capital Management LP | 522,900 | $1.36M | 0.06% | 00.0% | Unchanged |
| DC Funds, LP | 589,102 | $1.53M | 35.68% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 626,810 | $1.63M | 0.35% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $2.60M | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 1,097,348 | $2.85M | 0.00% | +259,046+30.9% | Added |
| Bank of America Corp | 1,531,463 | $3.98M | 0.00% | −2,129−0.1% | Reduced |
| Rubric Capital Management LP | 1,935,357 | $5.03M | 0.20% | +99,970+5.4% | Added |
| PFM Health Sciences, LP | 2,217,220 | $5.76M | 0.27% | +923,927+71.4% | Added |
| MPM Oncology Impact Management LP | 2,388,011 | $6.21M | 1.61% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $11.1M | 4.64% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 6,144,881 | $16.0M | 0.36% | +1,853,000+43.2% | Added |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −246,305−100.0% | Sold out |
| Tejara Capital Ltd | 0 | $0 | 0.00% | −128,800−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −101,221−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −26,501−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −22,064−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −10,729−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,030−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −74−100.0% | Sold out |